QF
KERX

QVT Financial’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

QVT Financial’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-626,200
Closed -$9.63M – 91
2014
Q2 		$9.63M Sell
626,200
-209,000
-25% -$2.96M 0.52% 56
2014
Q1 		$14.2M Sell
835,200
-18,800
-2% -$284K 0.81% 42
2013
Q4 		$11.1M Sell
854,000
-58,000
-6% -$693K 0.65% 48
2013
Q3 		$9.2M Hold
912,000
– – 0.63% 45
2013
Q2 		$6.81M Buy
+912,000
New +$7.13M 0.46% 47

Other funds holding KERX

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

QVT Financial's KERX Position: Q3 2014 in Review

QVT Financial sold out of Keryx Biopharmaceuticals Inc (KERX) in Q3 2014, closing a stake of 626,200 shares — an estimated $9.63M sold.

QVT Financial first reported a position in KERX in Q2 2013 and held it in 5 quarters. The position peaked at $14.2M in Q1 2014. 140 funds tracked by Wall St. Rank hold KERX as of Q3 2014.

  • QVT Financial reported no remaining Keryx Biopharmaceuticals Inc position as of Q3 2014 after selling out during the quarter.
  • QVT Financial sold 626,200 Keryx Biopharmaceuticals Inc shares in Q3 2014, an estimated $9.63M.
  • QVT Financial first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 5 quarters.
  • QVT Financial's Keryx Biopharmaceuticals Inc position peaked at $14.2M in Q1 2014.
  • 140 funds tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q3 2014.

Based on QVT Financial's 13F filing for Q3 2014, filed 14 Nov 2014.